The second half of this article describes the testing methods used by the authors to demonstrate the applicability of single-use mixing technology for virus inactivation.
Amélie Boulais
Advertisement
Amélie Boulais is process development consultant, Integrated Solutions Marketing at Sartorius Stedim Biotech.
Articles by Amélie Boulais
This article explores the use of single-use mixing technology in a detergent-based virus inactivation step during a monoclonal antibody production process.
Advertisement
Latest Updated Articles
Validating Virus Clearance in a Single-Use System Part 1: Film Adsorption and Virus Inactivation StudiesPublished: October 1st 2018 | Updated:
Single-Use Mixing Technology for Virus Clearance (Part 2: Compatibility, Leachables, and Scale-Up Studies)Published: November 1st 2018 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Challenges for Global Manufacturing of Vaccines
2
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
3
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
4
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
5
